发明名称 TARGETED APHERESIS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND IMMUNE DISORDERS
摘要 This invention uses “Targeted Apheresis” to treat patients with Rheumatoid Arthritis and other autoimmune and inflammatory disorders. “Targeted Apheresis” is a process whereby only the pathogenic and pro-inflammatory elements associated with the disease symptoms are simultaneously and selectively removed from the blood by passing the blood through an extracorporeal affinity device containing selective binding agents. Removal of these pathogenic and pro-inflammatory elements will ameliorate the symptoms of autoimmune disease and may prolong the period of disease remission.
申请公布号 US2016106905(A1) 申请公布日期 2016.04.21
申请号 US201514978910 申请日期 2015.12.22
申请人 SMITH HENRY J.;SMITH JAMES R. 发明人 SMITH HENRY J.;SMITH JAMES R.
分类号 A61M1/36;A61M1/34;B01D15/38 主分类号 A61M1/36
代理机构 代理人
主权项 1. A means of selectively removing pathological, pro-inflammatory and disease inciting factors from the blood of patients with rheumatoid arthritis and other autoimmune diseases using targeted apheresis.
地址 TEMECULA CA US